Physiologically-based pharmacokinetic and pharmacodynamic models for gemcitabine and birinapant in pancreatic cancer xenografts.
Physiologically-based pharmacokinetic and pharmacodynamic models for gemcitabine and birinapant in pancreatic cancer xenografts.
复制标题
DOI:
10.1007/s10928-018-9603-z
复制
发表时间:
2018-10
影响因子:
2.5
通讯作者:
Jusko WJ
中科院分区:
文献类型:
--
作者:
Zhu X;Trueman S;Straubinger RM;Jusko WJ
The anticancer effects of combined gemcitabine and birinapant were demonstrated as synergistic in PANC-1 cells in vitro. In this study, pharmacokinetic information derived from experiments and the literature was utilized to develop full physiologically-based pharmacokinetic (PBPK) models that characterize individual drugs. The predicted intra-tumor drug concentrations were used as the driving force within a linked PBPK/PD model for treatment-mediated changes in tumor volume in a xenograft mouse model. The efficacy of the drug combination in vivo was evaluated mathematically as exhibiting additivity. The network model developed for drug effects in the in vitro cell cultures was applied successfully to link the in vivo tumor drug concentrations with tumor growth inhibition, incorporating more mechanistic features and accounting for disparate drug interaction outcomes in vitro and in vivo.
登录
查看更多内容
影响因子:
--
作者:
Ebrahem Q;Mahfouz RZ;Ng KP;Saunthararajah Y
通讯作者:
Saunthararajah Y
影响因子:
3
作者:
Hurwitz, Herbert I.;Smith, David C.;Pitot, Henry C.;Brill, Jeffrey M.;Chugh, Rashmi;Rouits, Elisabeth;Rubin, Joseph;Strickler, John;Vuagniaux, Gregoire;Sorensen, J. Mel;Zanna, Claudio
通讯作者:
Zanna, Claudio
影响因子:
13.5
作者:
Bai, Longchuan;Smith, David C.;Wang, Shaomeng
通讯作者:
Wang, Shaomeng
影响因子:
5.7
作者:
Benetatos, Christopher A.;Mitsuuchi, Yasuhiro;Chunduru, Srinivas K.
通讯作者:
Chunduru, Srinivas K.
影响因子:
5.8
作者:
BOUFFARD, DY;LALIBERTE, J;MOMPARLER, RL
通讯作者:
MOMPARLER, RL